| Literature DB >> 29543674 |
Martina Baneckova1,2, Abbas Agaimy3, Simon Andreasen4,5, Tomas Vanecek6, Petr Steiner1,6, David Slouka7, Tomas Svoboda8, Marketa Miesbauerova1,2, Michael Michal1,2, Alena Skálová1,2.
Abstract
Secretory carcinoma, originally described as mammary analog secretory carcinoma (MASC), is a low-grade salivary gland tumor characterized by a t(12;15)(p13;q25) translocation, resulting in an ETV6-NTRK3 gene fusion. Most MASCs are localized to the parotid gland and intraoral minor salivary glands. Moreover, ETV6-rearranged carcinomas with secretory features have been reported recently in the thyroid (with and without a history of radiation exposure), skin, and in very rare instances in the sinonasal tract. Here, we describe 2 cases of primary MASC in the sinonasal tract and provide a detailed clinical and histopathologic characterization of their morphology, immunohistochemical profile, and genetic background and highlight features allowing for its separation from its recently described molecular mimicker, ETV6-rearranged low-grade sinonasal adenocarcinoma.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29543674 DOI: 10.1097/PAS.0000000000001048
Source DB: PubMed Journal: Am J Surg Pathol ISSN: 0147-5185 Impact factor: 6.394